
Xiaomei Wang
Chairman,
Global AI Inclusive Networks
As the Chairman of Global AI Inclusive Networks, Xiaomei Wang is a passionate advocate for empowering the next generation of AI professionals. Her unwavering commitment to inclusivity and diversity in the field underscores her vision of an equitable and accessible AI future. Through her leadership in this non-profit organization, she has become an NGO icon, blending her extensive experience with a fervent desire to cultivate a diverse and skilled AI community.
At PathoAI, Xiaomei's strategic vision as Founder and CEO has propelled the company into exciting new territories, particularly in AI-driven diagnostics, biopharmaceutical research, and innovative medical devices. PathoAI has recently pioneered cutting-edge AI multimodal large models to develop next-generation diagnostic tools, capable of analyzing multi-organ and multi-cancer images with unprecedented accuracy, underscoring its pivotal role in revolutionizing healthcare and improving patient outcomes.
Renowned for her international speaking engagements, Xiaomei shares her deep insights into AI within the healthcare sector, earning respect and acclaim globally. Her presentations delve into the intersection of AI and healthcare, exploring ground breaking solutions, ethical considerations, and the future landscape of AI in industries.
With a trailblazing 19-year tenure at IBM, where she spearheaded pioneering projects across North America, Europe, Asia Pacific, and South America, Xiaomei's rich background adds depth to her contributions to global AI discussions. Her credentials as a certified Independent Director, IBM Certified Thought Leader, and The Open Group Distinguished Professional further solidify her status as a leading authority in the field.
Beyond her impactful leadership and speaking engagements, Xiaomei actively shapes the academic landscape as a guest professor in the Next Generation Graduate Program at CSIRO in Australia and at Zhejiang University of Finance & Economics. She also participates in various professional committees. A best-selling author, her notable works include "Industry Innovation in the Era of Artificial Intelligence – The AI Compass" and "AI 3.0", making her a prominent voice in the discourse surrounding technology and innovation
At PathoAI, Xiaomei's strategic vision as Founder and CEO has propelled the company into exciting new territories, particularly in AI-driven diagnostics, biopharmaceutical research, and innovative medical devices. PathoAI has recently pioneered cutting-edge AI multimodal large models to develop next-generation diagnostic tools, capable of analyzing multi-organ and multi-cancer images with unprecedented accuracy, underscoring its pivotal role in revolutionizing healthcare and improving patient outcomes.
Renowned for her international speaking engagements, Xiaomei shares her deep insights into AI within the healthcare sector, earning respect and acclaim globally. Her presentations delve into the intersection of AI and healthcare, exploring ground breaking solutions, ethical considerations, and the future landscape of AI in industries.
With a trailblazing 19-year tenure at IBM, where she spearheaded pioneering projects across North America, Europe, Asia Pacific, and South America, Xiaomei's rich background adds depth to her contributions to global AI discussions. Her credentials as a certified Independent Director, IBM Certified Thought Leader, and The Open Group Distinguished Professional further solidify her status as a leading authority in the field.
Beyond her impactful leadership and speaking engagements, Xiaomei actively shapes the academic landscape as a guest professor in the Next Generation Graduate Program at CSIRO in Australia and at Zhejiang University of Finance & Economics. She also participates in various professional committees. A best-selling author, her notable works include "Industry Innovation in the Era of Artificial Intelligence – The AI Compass" and "AI 3.0", making her a prominent voice in the discourse surrounding technology and innovation
Sessions
-
11-Jun-2025Sustainable Innovation StageHow Women Leaders Are Driving Inclusive Innovation